Proxy War-Front Latest: Amylin, Vanda Rocked By Dissident Shareholders

In tough times, patience for failing drugs and restructuring programs wears particularly thin.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet